TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
MBX

MBX Biosciences, Inc.

Healthcare · Biotechnology

57.90$ -6.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MBX
Line item 2022 2023 2024 2025
-0.73 -1.00 -1.64 -2.19
0.00 0.00 0.01 -0.10
0.01 0.06 0.16 0.24
0.04 -0.02 0.14 0.04
0.01 0.00 0.03 0.05
-0.36 -0.97 -4.81 -2.29
0.31 0.00 – –
1.45 2.17 7.01 5.19
0.36 0.20 0.56 0.71
-0.74 -1.01 -1.66 -2.24

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?